PMC:7105881 / 53468-53644 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1663","span":{"begin":6,"end":21},"obj":"Disease"}],"attributes":[{"id":"A1663","pred":"tao:has_database_id","subj":"1663","obj":"MESH:D014615"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ified Vaccinia Ankara (MVA) (Veit et al., 2018). This may be potentially a consequence of the weak immunogenicity and/or protective efficacy of non-S structural proteins, furth"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T307","span":{"begin":161,"end":169},"obj":"Body_part"}],"attributes":[{"id":"A307","pred":"fma_id","subj":"T307","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"ified Vaccinia Ankara (MVA) (Veit et al., 2018). This may be potentially a consequence of the weak immunogenicity and/or protective efficacy of non-S structural proteins, furth"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T266","span":{"begin":6,"end":14},"obj":"Disease"},{"id":"T267","span":{"begin":23,"end":26},"obj":"Disease"}],"attributes":[{"id":"A266","pred":"mondo_id","subj":"T266","obj":"http://purl.obolibrary.org/obo/MONDO_0002595"},{"id":"A267","pred":"mondo_id","subj":"T267","obj":"http://purl.obolibrary.org/obo/MONDO_0012481"}],"text":"ified Vaccinia Ankara (MVA) (Veit et al., 2018). This may be potentially a consequence of the weak immunogenicity and/or protective efficacy of non-S structural proteins, furth"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T640","span":{"begin":42,"end":46},"obj":"http://purl.obolibrary.org/obo/CLO_0001185"},{"id":"T641","span":{"begin":73,"end":74},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"ified Vaccinia Ankara (MVA) (Veit et al., 2018). This may be potentially a consequence of the weak immunogenicity and/or protective efficacy of non-S structural proteins, furth"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T9220","span":{"begin":23,"end":26},"obj":"Chemical"},{"id":"T74554","span":{"begin":161,"end":169},"obj":"Chemical"}],"attributes":[{"id":"A61194","pred":"chebi_id","subj":"T9220","obj":"http://purl.obolibrary.org/obo/CHEBI_25351"},{"id":"A73138","pred":"chebi_id","subj":"T74554","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"ified Vaccinia Ankara (MVA) (Veit et al., 2018). This may be potentially a consequence of the weak immunogenicity and/or protective efficacy of non-S structural proteins, furth"}

{"project":"2_test","denotations":[{"id":"32265848-30558354-36511226","span":{"begin":42,"end":46},"obj":"30558354"}],"text":"ified Vaccinia Ankara (MVA) (Veit et al., 2018). This may be potentially a consequence of the weak immunogenicity and/or protective efficacy of non-S structural proteins, furth"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T871","span":{"begin":6,"end":14},"obj":"NCBITaxon:7742"},{"id":"T872","span":{"begin":99,"end":113},"obj":"BV_15"},{"id":"T94849","span":{"begin":6,"end":14},"obj":"NCBITaxon:7742"},{"id":"T8643","span":{"begin":99,"end":113},"obj":"BV_15"}],"text":"ified Vaccinia Ankara (MVA) (Veit et al., 2018). This may be potentially a consequence of the weak immunogenicity and/or protective efficacy of non-S structural proteins, furth"}